600,000 inhalers recalled for defects - WTOC-TV: Savannah, Beaufort, SC, News, Weather & Sports

600,000 inhalers recalled for defects

Inhalers have been recalled because the drug delivery system is defective. (Source: Ventolin.com) Inhalers have been recalled because the drug delivery system is defective. (Source: Ventolin.com)

(RNN) - GlaxoSmithKline is recalling nearly 600,000 prescription inhalers over defects, the FDA announced.

The voluntary recall targets Ventolin HFA (albuterol sulfate) Inhalation Aerosol, distributed via prescription nationwide.

The manufacturer said the drug delivery system is defective.

The following products are being recalled:

  • lot number 6ZP9848, expiration date March 2018;
  • lot number 6ZP0003, 6ZP9944, expiration date of April 2018.

The FDA classifies the recall as Class II, which means use of the product "may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote."

Those with products under a recall notice should contact their healthcare professional, the FDA said, or return the product to the place of purchase for a refund.

Copyright 2017 Raycom News Network. All rights reserved.

  • Latest health & fitness newsLatest health & fitness newsMore>>

  • Parenting of the future: Many embryos, each with DNA profile

    Parenting of the future: Many embryos, each with DNA profile

    Wednesday, April 18 2018 1:23 AM EDT2018-04-18 05:23:15 GMT
    Saturday, April 21 2018 5:56 AM EDT2018-04-21 09:56:53 GMT
    (ASRM via AP). This undated microscope image provided by the American Society for Reproductive Medicine in January 2018 shows a trophectoderm biopsy, in which cells from the outer layer of an embryo that develop into the placenta and amniotic membranes...(ASRM via AP). This undated microscope image provided by the American Society for Reproductive Medicine in January 2018 shows a trophectoderm biopsy, in which cells from the outer layer of an embryo that develop into the placenta and amniotic membranes...

    A prominent biomedical ethics expert predicts that in 20 to 40 years, many parents will choose babies from dozens of embryos, after examining DNA information on each.

    More >>

    A prominent biomedical ethics expert predicts that in 20 to 40 years, many parents will choose babies from dozens of embryos, after examining DNA information on each.

    More >>
  • Warming, not cooling, donated livers may improve transplants

    Warming, not cooling, donated livers may improve transplants

    Wednesday, April 18 2018 2:23 PM EDT2018-04-18 18:23:24 GMT
    Saturday, April 21 2018 5:56 AM EDT2018-04-21 09:56:46 GMT
    (OrganOx via AP). This 2016 photo provided by OrganOx shows Drs. David Nasralla and Annemarie Weissenbacher with the company's metra device holding a liver in Oxford, England. On Wednesday, April 18, 2018, British researchers said that keeping at least...(OrganOx via AP). This 2016 photo provided by OrganOx shows Drs. David Nasralla and Annemarie Weissenbacher with the company's metra device holding a liver in Oxford, England. On Wednesday, April 18, 2018, British researchers said that keeping at least...
    Study suggests warming, not cooling, donated livers may improve organ transplants.More >>
    Study suggests warming, not cooling, donated livers may improve organ transplants.More >>
  • UN health agency: Dengue vaccine shouldn't be used widely

    UN health agency: Dengue vaccine shouldn't be used widely

    Thursday, April 19 2018 10:56 AM EDT2018-04-19 14:56:41 GMT
    Saturday, April 21 2018 5:56 AM EDT2018-04-21 09:56:24 GMT
    The World Health Organization says that the first-ever vaccine for dengue needs to be dealt with in "a much safer way" and mostly given to people previously infected with the disease.More >>
    The World Health Organization says that the first-ever vaccine for dengue needs to be dealt with in "a much safer way" and mostly given to people previously infected with the disease.More >>
Powered by Frankly